RNAC
Cartesian Therapeutics, Inc. · Healthcare
President and CEO Carsten Brunn sold $162K of Cartesian Therapeutics, Inc.
Sold$162,077
$6.82Price
23,766Shares
−7%Stake
What RNAC did after the filing
- The stock from Thu, Jan 8 close, $8.12
- −14.0%
- S&P 500, same days
- −1.0%
Measured over 30 trading days, to the Feb 23 close.
Traded Tue, Jan 6. Filed Thu, Jan 8, 11:20 AM ET, during the session. Returns use the Jan 8 close and the Feb 23 close. Not investment advice.